New Report on Cancer Registry Software Market Report Study with share, new functions, strategy for Cancer Reporting, Patient Care, Medical Research and it is driven by cancer registries, investments in healthcare IT, presence of major cancer registry software-developing players.
Cancer patient registry software market is projected to reach USD 91 million by 2024 from USD 56 million in 2019, at a CAGR of 10.4% during forecast period. The on-premise model segment dominated this market in 2018 primarily due to the higher adoption of on-premise solutions among end users as a result of advantages such as high security, low risk of external attacks and data breaches, and control over software upgrades. It will also enable stakeholders to understand pulse of market and provide them with information on key market drivers, restraints, challenges, and opportunities.
Download Free PDF Brochure Now on Cancer Registry Software Market Report at http://www.rnrmarketresearch.com/contacts/request-sample?rname=2075145 .
Cancer patient registry software market is segmented into commercial and public databases. The commercial databases segment dominated this market in 2018 owing to the ease of expansion of these databases, which allows a large user base to access, add, or modify information simultaneously. Also, owing to the advantages offered by commercial databases, a large number of pharmaceutical and medical device companies are opting for these databases.
Commercial databases accounted for the largest share of the cancer patient registry software market, by database type, in 2018. The medical research & clinical studies segment to witness the highest growth in the cancer patient registry software market, by functionality, during the forecast period. North American market to witness high growth during the forecast period.
North America was largest regional for cancer patient registry software market. This market is also estimated to grow at a higher CAGR during the forecast period. Factors like increasing prevalence of cancer, favorable government initiatives, rising pressure to improve quality of care and reduce healthcare costs, rising adoption of EHRs, & growing use of cancer patient registry data for post-marketing surveillance are driving the growth of this market.
Get 10% Discount Now on Cancer Patient Registry Software Market Research Report at http://www.rnrmarketresearch.com/contacts/discount?rname=2075145 .
Cancer patient registry software market report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cancer patient registry software market and its sub segments. Also, this report will help stakeholders to better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.
Report aims at estimating cancer patient registry software size and future growth potential of the market across different segments, such as type, deployment model, database, functionality, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Prominent players in Cancer patient registry software market are include Elekta (Sweden), Electronic Registry Systems, Inc. (US), Onco, Inc. (US), C/NET Solutions (US), Rocky Mountain Cancer Data Systems (US), and McKesson Corporation (US).
More Information on “Cancer Registry Software Market by Type (Standalone, Integration), Delivery (On-premise, Cloud), Database (Commercial, Public), Functionality (Cancer Reporting, Patient Care, Medical Research), End User, Region – Global Forecast to 2024” Report Now Available at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=2075145 .
The cancer patient registry software market is segmented into private payers; hospitals & medical practices; research centers; pharmaceutical, biotechnology, & medical device companies; and government organizations & third-party administrators. The research centers segment is estimated to grow at the highest CAGR during the forecast period.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 – 28%; Tier 2- 19%; and Tier 3- 53%
- By Designation: C-level- 51%; D-level- 28%; and Others-21%
- By Region: North America-70%; Europe- 30%
Key Benefits of Buying the Report
Cancer patient registry software market is segmented into standalone and integrated software. The standalone software segment accounted for a larger share in 2018 primarily due to the significant use of standalone software by government organizations & TPAs for population health management (due to its adaptability and interoperability). Research centers use cancer patient registry software primarily to track patients who are eligible for clinical trials and product development.